Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

Sputnik V certain copes with the Indian strain, expert says

The Sputnik V vaccine remained highly effective. According to the expert, it protects 100% from severe forms of the disease and deaths.

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...

Positive results were obtained for the drug Zanubrutinib in a comparative trial with Isrutinib

Brukinsa® (zanubrutinib) is under regulatory review for relapsed, refractory MCL in the Russian Federation with potential approval at the end of the 2021.

COVID-19 pathogenetic treatment is approved as an additional indication for olokizumab

Approval for a new indication will help healthcare professionals make streamlined decisions to administer preemptive anticytokine therapy.

Russia’s First Covid-19 Express Test Receives EU Certification

The company is planning deliveries to the EU in the near future, where the market in volume terms amounts to hundreds of millions of tests per month.

NANOLEK will invest 5 billion rubles in the full production cycle

Nanolek, a biopharmaceutical company, announces a plan to invest 5 billion rubles over 3 years in its full-cycle vaccine production facility in the Kirov region and an R&D Center for Biotech Medicines in Moscow.
spot_img

Expert Articles

spot_img